Optic atrophy
Optic atrophy is not a single disease. It is the final outcome of various lesions of the optic nerve and damage to its myelin sheath or retinal ganglion cells and their axons, resulting in loss of nerve fibers and gliosis. It is a common term in pathology. It usually occurs in the axonal degeneration of ganglion cells between the retina and the lateral geniculate body. Due to the degeneration and atrophy of nerve fibers, patients often have decreased visual function and reduced visual field.
-
Site of disease:
Eye -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Vision is often foggy and blurry Visual impairment Paranasal sinus hypoplasia Visual impairment Narrowed visual field -
Concurrent disease:
Related Drugs
Inosine for injection
Indication: It is clinically used for leukopenia or thrombocytopenia, various acute and chronic liver diseases, heart diseases such as cor pulmonale, central retinitis, optic atrophy and other diseases.
Manufacturer:
Hainan Tongyong Kangli Pharmaceutical Co., Ltd.
Inosine for injection
Indication: It is clinically used for leukopenia or thrombocytopenia, various acute and chronic liver diseases, heart diseases such as cor pulmonale, central retinitis, optic atrophy and other diseases.
Manufacturer:
Zhejiang Hacon Pharmaceutical Co., Ltd.
Inosine for injection
Indication: It is clinically used for leukopenia or thrombocytopenia, various acute and chronic liver diseases, heart diseases such as cor pulmonale, central retinitis, optic atrophy and other diseases.
Manufacturer:
Shanxi PUDE Pharmaceutical Co., Ltd.
Inosine for injection
Indication: It is clinically used for leukopenia or thrombocytopenia, various acute and chronic liver diseases, heart diseases such as cor pulmonale, central retinitis, optic atrophy and other diseases.
Manufacturer:
Shanxi PUDE Pharmaceutical Co., Ltd.
Inosine for injection
Indication: It is clinically used for leukopenia or thrombocytopenia, various acute and chronic liver diseases, heart diseases such as cor pulmonale, central retinitis, optic atrophy and other diseases.
Manufacturer:
Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Inosine injection (intramuscular injection)
Indication: It is clinically used for leukopenia or thrombocytopenia, various acute and chronic liver diseases, heart diseases such as cor pulmonale, central retinitis, optic atrophy and other diseases.
Inosine injection (intramuscular injection)
Indication: It is clinically used for leukopenia or thrombocytopenia, various acute and chronic liver diseases, heart diseases such as cor pulmonale, central retinitis, optic atrophy and other diseases.
Inosine injection (intravenous)
Indication: It is clinically used for leukopenia or thrombocytopenia, various acute and chronic liver diseases, heart diseases such as cor pulmonale, central retinitis, optic atrophy and other diseases.
Manufacturer:
Shandong Shenglu Pharmaceutical Co., Ltd.
Inosine injection
Indication: It is clinically used for leukopenia or thrombocytopenia, various acute and chronic liver diseases, heart diseases such as cor pulmonale, central retinitis, optic atrophy and other diseases.
Manufacturer:
Shanxi JINXIN DOUBLE-CRANE Pharmaceutical Co., Ltd.
Inosine injection
Indication: It is clinically used for leukopenia or thrombocytopenia, various acute and chronic liver diseases, heart diseases such as cor pulmonale, central retinitis, optic atrophy and other diseases.
Manufacturer:
Suicheng Pharmaceutical Co., Ltd.
Related Ingredients